SCANDINAVIAN CHEMOTECH AB Scandinavian ChemoTech AB (publ) announced the appointment of Dr. Mufti as Medical Director. Dr. Mufti has been playing a crucial part as a consulting Medical Advisor where he, amongst other things, has been representing ChemoTech and technology in the preparations to start the TSE trial at AIIMS Jodhpur. Dr. Mufti is a board-certified onco-pathologist and translational oncology professional with extensive experience in the design and execution of early-phase clinical trials and non-clinical regulatory studies.
He did his medical graduated from the prestigious Government Medical College, Srinagar and completed his Pathology residency at the National Board of Examinations and Translational Medicine training at the University of Edinburgh. He brings in over 15 years of experience in Oncology research and has extensive experience in Head and Neck, Breast and Soft Tissue tumours.
